dihexa clinical trial human studies trials alphabiomedlabs #dihexa #neuroplasticityresearch #hgfcmet #neurosciencescience dihexa clinical trials status Dihexa – AngIV-Analog Dihexa Rescues Cognitive Impairment

Stack protocol: BPC-157: 250 to 500 mcg subcutaneous, once or twice a day Inject near the injury when you can reach it TB-500: 2 to 2.5 mg subcutaneous, twice a week (loading phase) Inject away from the injury, lower abdomen or outer thigh works fine 2 mg once a week (maintenance phase) Both run at the same time through the loading phase

Limitacin del uso para investigacin Destinado exclusivamente a la investigacin de laboratorio y in vitro No apto para el consumo humano No est autorizado para uso veterinario No est destinado a fines diagnsticos No est destinado a usos teraputicos No est permitido su uso clnico Slo para investigacin Analizado de forma independiente por Liquilabs s.r.o

Administration Codes (The Work You Did) These codes tell the payer, I counseled the patient and safely administered the vaccine. This is where you make your margin

Temperature fluctuations, light exposure, or contamination can shorten effective life significantly